The second phase, to last until September 20, is held in Vu Thu district, the northern province of Thai Binh. (Photo: VNA) More than 50 volunteers received the jabs in themorning, and the number is expected to reach about 80 on the day, according toAssociate Prof. Dr. Vu Dinh Thiem, Director of the National Institute of Hygieneand Epidemiology (NIHE)’s clinical trial centre.
The second phase, to last until September 20, is heldin Vu Thu district, the northern province of Thai Binh. It saw theparticipation of 374 volunteers who have been chosen and classified into threegroups for the 3 mcg and 6 mcg dosages and a dose of AstraZeneca vaccine.
Covivac has been developed and produced by theInstitute of Vaccines and Medical Biologicals (IVAC). It is the secondhomegrown vaccine approved by the Ministry of Health for clinical trials, afterNano Covax.
Dr. Duong Huu Thai, IVAC Director, said the thirdphase of the human trials is expected to begin in December after the safety andimmunogenicity in the second phase are confirmed.
The third phase would be conducted on more than 4,000volunteers in Khanh Hoa, Bac Ninh and Thai Binh provinces.
Nguyen Ngo Quang, Deputy Director of the Department ofScience, Technology and Training under the Ministry of Health, said at leasta homegrown vaccine will be licensed for circulation by the end of this year.
For Nano Covax, Quang said the producer and researcherson September 14 submitted the supplemented dossier on the vaccine and completedregistration procedures.
Regarding the clinical trials of ARCT-154, a mRNAvaccine developed by US company Arcturus Therapeutics, he said the healthministry has approved the implementation of the second and third trial phases./.